Nuria Porta

Lead Statistician, Clinical Trials & Statistics Unit @ICR_CTSU at The Institute of Cancer Research @ICR_london

[Nuria Porta @NPortaStat]

Important guidance for reporting ML-prediction models: +transparency on development and validation; helpful to inform how (reliably? realistically?) these can inform clinical management @ICRharry @MaggieCheang

[Gary Collins @GSCollins]

NEW PAPER out today in @BMJ_latest TRIPOD+AI: reporting recommendations for studies developing or validating prediction models for use in healthcare that use #machinelearning methods

https://t.co/ed9oiB1MVG

#ArtificialIntelligence #AIstandards #OpenAccess

Please share 🙏

[Maarten van Smeden @MaartenvSmeden]

Mandatory periodic reminder to BMJ Statistics Notes. Little nuggets of statistical wisdom at no charge
https://t.co/8sHAbuQjLZ

[Prof Emma Hall @EmmaHall71]

A pleasure @ICRharry! Very pleased and proud to see @ICR_CTSU’s first (and second @HollyTovey) non-clinical PhD student graduate earlier in the week.
#ICRawards2024 @ICR_London @UoLondon

[Maggie Cheang @MaggieCheang]

Congrats @HollyTovey! My first non-clinical PhD student. This journey with you has been a thrilling voyage of discovery. Big day for @ICR_CTSU ! Congrats @ICRharry #ICRGRAD #ICRAward2024 @UoLondon

[Nuria Porta @NPortaStat]

Proud supervisors overload!

[Maggie Cheang @MaggieCheang]

Congrats @HollyTovey! My first non-clinical PhD student. This journey with you has been a thrilling voyage of discovery. Big day for @ICR_CTSU ! Congrats @ICRharry #ICRGRAD #ICRAward2024 @UoLondon

[Nuria Porta @NPortaStat]

and @HollyTovey #ICRGrad #ICRAwards2024

[Nuria Porta @NPortaStat]

@ICRharry #ICRGrad #ICRAwards2024

[Nuria Porta @NPortaStat]

@ICRharry #ICRGrad #ICRAwards2024

[Nuria Porta @NPortaStat]

Big day for @ICRharry & @HollyTovey! everything ready... @ICR_CTSU

[Nuria Porta @NPortaStat]

Big day for @ICRharry & @HollyTovey! everything ready... @ICR_CTSU

[The ICR @ICR_London]

🎉👏We're excited to celebrate so many incredible people at our graduation and award ceremony!

We'll be celebrating our student graduates, honorary degree recipients, prize winners, and people being made associates and members of the ICR.👩‍🎓👨‍🎓

#ICRGrad #ICRAwards2024 @UoLondon

[Frank Harrell @f2harrell]

Video of yesterday's talk for @consiliumsci on making clinical trials more efficient is now available: https://t.co/8Zs9h11doU #clinicaltrials #Statistics @vandy_biostat

[Nuria Porta @NPortaStat]

Response assessment of bone disease is an unmet need in mCRPC, resulting in people with bone-predominant disease excluded from early phase trials of new promising drugs, or staying on treatment longer with ineffective drugs. Very interesting data @RaqPerezLopez @quimmateo!

[Joaquin Mateo @quimmateo]

Our latest paper is now out in @EUplatinum -A prospective study of whole-body MRI in mCRPC with bone mets: the IPROMET clinical trial. Work with @RaqPerezLopez @radiomicsVHIO
https://t.co/Dg3UjSGvdO

[Nuria Porta @NPortaStat]

Glad to see results of the NICAM phase 2 trial are finally out! NICAM is one of the first biomarker-driven trials run by @ICR_CTSU in rare melanoma cancers with few therapeutic options available #teamscience #clinicaltrials

[Follow us on Bluesky @ICR-CTSU @ICR_CTSU]

The results of our NICAM study have been published in @CellRepMed. NICAM investigates the use of a drug called nilotinib in rare forms of advanced #Melanoma with a mutation in a specific gene. https://t.co/DbRYBdG2DJ

[Prof Emma Hall @EmmaHall71]

Do get in touch if you are interested in this post. Exciting opportunities linked to new & existing ph1-3 trials. Working with great team @ICR_CTSU incl.
@ChristinaBYap @NPortaStat @MaggieCheang @JudithBliss15 and clinicians & scientists @ICR_London @royalmarsdenNHS & beyond

[Nuria Porta @NPortaStat]

Another publication derived from the BC2001 trial in muscle-invasive bladder cancer - learning as much as we can from our trials! #clinicaltrials #secondaryresearch #biomarkers

[Follow us on Bluesky @ICR-CTSU @ICR_CTSU]

A paper using samples from the BC2001 #ClinicalTrial has been published in @eBioMedicine. The project investigates whether a 24-gene-signature could identify patients who benefitted from chemotherapy in BC2001.
https://t.co/VkEPSjR89M

[Prof Ananya💙 @achoud72.bsky.social @achoud72]

🚨Its out! Does #hypoxiagene signature predict outcome to #CRT in #MIBC?🚨@robert_huddart
@NPortaStat @EmmaHall71 @Prof_Nick_James @nuradh @syeepei @ProfSyedHussain @hilseth_mistrov #WhereisHoskin @MCRCnews @UoM_DCS @CRUKresearch @UKRI_News @eBioMedicine
https://t.co/0WGuJRJs3X

[The ICR @ICR_London]

👑We're so proud to receive a #QAPrize from Her Majesty The Queen today for our #BreastCancer research.

Read more about the special event 👇

https://t.co/VEdvwquXD6

[Follow us on Bluesky @ICR-CTSU @ICR_CTSU]

Congratulations to @MaggieCheang who was awarded the title of Reader this week.

[Nuria Porta @NPortaStat]

@JonAnker1 @TumorBoardTues @MattGalsky @MPishvaian @JohnEbbenMDPhD @ThreadReaderApp unroll

[Nuria Porta @NPortaStat]

@TumorBoardTues @MattGalsky @JonAnker1 @MPishvaian @JohnEbbenMDPhD @ThreadReaderApp unroll

[Nuria Porta @NPortaStat]

Thanks to this @NIHRresearch funding, Katie will have dedicated time for #clinicaltrials #methodology research. Core to this, her contribution to upcoming projects of the @NIHRStatistics Imaging Studies group https://t.co/lS2H3XsWSH

[Follow us on Bluesky @ICR-CTSU @ICR_CTSU]

Congratulations to our statistician Katie Biscombe who has received a @NIHRresearch pre-doctoral fellowship. She will be working with @NPortaStat, Prof @EmmaHall71 and Dr Hensor @UniversityLeeds on methodological research of studies that incorporate imaging at their core.

[Nuria Porta @NPortaStat]

A lot of work behind this picture, well done team!!!! @ChristinaBYap

[Follow us on Bluesky @ICR-CTSU @ICR_CTSU]

The DEFINE study team have also been running a workshop to disseminate the SPIRIT and CONSORT extensions for early phase dose-finding #ClinicalTrials.